Novel Anticoagulants (CONG2014-21)

This course includes the following:

 

New Agents with FDA-Approved Vein Indications and Those in Development
Gary Raskob, PhD

How to Pick the Best Therapy for DVT, SVT, EHIT and Prophylaxis
John Bartholomew, MD

Management of Bleeding and Complications with the New Anticoagulant Agents
Jack Ansell, MD

Question and Answer
All Faculty

Steps to Successfully Complete This Activity

To participate in this educational activity please follow the steps listed below.

If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.

  1. To begin the activity click the START COURSE button.
  2. Progress through course content by using the NEXT button.
  3. Complete all required items in the course.
  4. Track your progress using the Course Progress menu.
  5. On the final page of the activity a link will be provided to download your certificate.

Target Audience

The content of this activity is designed to meet the needs of the following target audience:  phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.

Course summary
Course opens: 
11/24/2014
Course expires: 
11/24/2018
Cost:
$30.00
Rating: 
0
NAMEROLECOMMERCIAL INTERESTTYPE OF RELATIONSHIP
Jack Ansell, MDSpeaker

Bristol Myers Squibb

Pfizer

Boehringer Ingelheim

Daiichi Sankyo

Perosphere Inc.

Consultant; Speaker

Consultant; Speaker

Consultant; Speaker

Consultant

Consultant

John Bartholomew, MDSpeaker

Daiichi Sankyo

Genentech

Consultant

Consultant

Carl Black, MDContent ReviewerNonen/a
Yung-Wei Chi, DO, FAHA, FSVMPlannerNonen/a
Stephen H. MossStaffNonen/a
Diana L. Neuhardt, RVT, RPhSContent ReviewerBTGSpeaker
Gary Raskob, PhDModerator; Speaker

Daiichi Sankyo

BMS

Bayer Healthcare

Janssen Pharmaceuticals

Pfizer

Johnson and Johnson

Consultant

Consultant

Consultant

Consultant

Consultant

Consultant

Saundra Spruiell, DO, FACPh, RPVIPlannerNonen/a

Disclaimer

The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

Discussion of Off-Label Use

Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.

Reproduction Prohibited

Reproduction of this material is not permitted without written permission from the copyright owner.

Available Credit

Accreditation Period

Course opens: 
11/24/2014
Course expires: 
11/24/2018

Price

Cost:
$30.00
Please login or register to take this course.